Director Declaration

Summary by AI BETAClose X

BlackRock Income and Growth Investment Trust plc announced that its Chairman and Non-Executive Director, Graeme Proudfoot, has been appointed as a Non-Executive Director of BioPharma Credit PLC, effective September 15, 2026. This disclosure is made in accordance with Listing Rule 6.4.9(2)R.

Disclaimer*

 

 

BlackRock Income and Growth Investment Trust plc
(LEI – 5493003YBY59H9EJLJ16)

Disclosure pursuant to paragraph 6.4.9(2)R of the Listing Rules

Non-Executive Director Declaration

 

BlackRock Income and Growth Investment Trust plc (‘the Company’) hereby gives notification in accordance with Listing Rule 6.4.9(2)R, that Graeme Proudfoot, Chairman and Non-Executive Director of the Company, has been appointed as a Non-Executive Director of BioPharma Credit PLC with effect from today (15 September 2026).

 

All enquiries:
Kevin Mayger
BlackRock Investment Management (UK) Limited

Company Secretary
Tel: 0207 743 1098

 

15 September 2026
 




Release

UK 100

Latest directors dealings